Australia Rosacea Treatment Market Size & Outlook, 2025-2030

The rosacea treatment market in Australia is expected to reach a projected revenue of US$ 38.3 million by 2030. A compound annual growth rate of 9.1% is expected of Australia rosacea treatment market from 2025 to 2030.
Revenue, 2024 (US$M)
$22.8
Forecast, 2030 (US$M)
$38.3
CAGR, 2025 - 2030
9.1%
Report Coverage
Australia

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Australia rosacea treatment market, 2018-2030 (US$M)

Australia rosacea treatment market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Australia rosacea treatment market highlights

  • The Australia rosacea treatment market generated a revenue of USD 22.8 million in 2024 and is expected to reach USD 38.3 million by 2030.
  • The Australia market is expected to grow at a CAGR of 9.1% from 2025 to 2030.
  • In terms of segment, antibiotics was the largest revenue generating drug class in 2024.
  • Alpha agonists is the most lucrative drug class segment registering the fastest growth during the forecast period.


Rosacea treatment market data book summary

Market revenue in 2024USD 22.8 million
Market revenue in 2030USD 38.3 million
Growth rate9.1% (CAGR from 2025 to 2030)
Largest segmentAntibiotics
Fastest growing segmentAlpha agonists
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationAntibiotics, Alpha agonists, Retinoids, Corticosteroids, Immunosuppressants


Other key industry trends

  • In terms of revenue, Australia accounted for 1.1% of the global rosacea treatment market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China rosacea treatment market is projected to lead the regional market in terms of revenue in 2030.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 167.2 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Rosacea Treatment Market Companies

Name Profile # Employees HQ Website
Aclaris Therapeutics View profile 101-250 Malvern, Pennsylvania, United States, North America http://www.aclaristx.com
Sol-Gel Technologies View profile 51-100 Nes Ziyyona, HaMerkaz, Israel, Asia http://www.sol-gel.com/
Mayne Pharma Group Ltd View profile 160 1538 Main North Road, Salisbury South, Salisbury, SA, Australia, 5106 http://www.maynepharma.com
Bausch Health Companies Inc View profile 20270 2150 Saint Elzear Boulvard West, Laval, QC, Canada, H7L 4A8 https://www.bauschhealth.com
LEO Pharma View profile 1001-5000 Parsippany, New Jersey, United States, North America http://www.leo-pharma.us/
Galderma Group AG Registered Shares View profile - Zählerweg 10, Zug, Switzerland, 6300 https://www.galderma.com
Bayer AG View profile 99723 Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 https://www.bayer.com
Nestle SA View profile 270000 Avenue Nestle 55, Vevey, Switzerland, CH-1800 https://www.nestle.com
Pfizer Inc View profile 88000 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 https://www.pfizer.com
AbbVie Inc View profile 50000 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 http://www.abbvieinvestor.com

Australia rosacea treatment market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to rosacea treatment market will help companies and investors design strategic landscapes.


Antibiotics was the largest segment with a revenue share of 55.7% in 2024. Horizon Databook has segmented the Australia rosacea treatment market based on antibiotics, alpha agonists, retinoids, corticosteroids, immunosuppressants covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Australia rosacea treatment market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Australia rosacea treatment market databook

  • Our clientele includes a mix of rosacea treatment market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Australia rosacea treatment market , including forecasts for subscribers. This country databook contains high-level insights into Australia rosacea treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Australia rosacea treatment market size, by drug class, 2018-2030 (US$M)

Australia Rosacea Treatment Market Outlook Share, 2024 & 2030 (US$M)

Australia rosacea treatment market size, by drug class, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online